Henry Waxman said...

I think a lot of the problem is that either the FDA does not have the resources or there are problems at FDA in processing what is going on or there are problems with the developers.

Context

Waxman discusses issues with FDA resources and device approval processes.

07/19/2011

https://congress.gov...